醫療保健領域量子運算市場－全球產業規模、佔有率、趨勢、機會和預測：按組件、技術、應用、地區和競爭格局分類，2021-2031年

全球醫療保健量子運算市場預計將從 2025 年的 1,389.4 億美元成長到 2031 年的 1.17369 兆美元，複合年成長率將達到 42.71%。

在該領域，動態原理，特別是量子糾纏和量子疊加原理，被應用於處理複雜的生物和化學數據，其速度比傳統超級電腦快得多。市場的主要促進因素是迫切需要加速藥物研發進程，以及對高精度基因組分析日益成長的需求，以促進個人化醫療。滿足這些需求需要先進的模擬能力，能夠以傳統運算方法無法企及的精度模擬分子間交互作用，進而顯著降低研發成本。

然而，在技術成熟度方面仍存在著許多挑戰，尤其是在雜訊環境下維持量子位元相干性和控制錯誤率的難度。這種硬體不穩定性目前限制了實際應用的擴充性，因此需要製定謹慎的整合策略。皮斯托亞聯盟的報告顯示，到2025年，約有18%的生命科學機構計劃在其實驗室中使用量子計算。儘管這項技術具有變革性的潛力，但這一數字凸顯了仍然存在的巨大技術挑戰。

市場促進因素

全球醫療保健領域量子運算市場的最大驅動力是分子模擬和藥物發現的加速。傳統計算方法無法以必要的精度模擬分子間相互作用的複雜性，這成為藥物研發的瓶頸。量子演算法透過在原子層面模擬化學過程來克服這項挑戰，從而顯著減少識別潛在候選藥物所需的時間和資金。認知到這項潛力，主要企業正在投入大量資源。例如，根據2024年5月發布的題為「Novo Holdings向量子技術Start-Ups生態系統投入14億丹麥克朗」的新聞稿，該公司已專門撥款1.88億歐元用於開發旨在直接應用於生命科學領域的量子技術。

推動市場成長的第二個關鍵因素是公共和私人投資的增加。這些投資為實驗技術的成熟奠定了必要的基礎。各國政府和私人機構正在建立專門的中心，以解決硬體不穩定問題，並擴大量子技術在診斷和治療領域的實際應用。例如，英國政府在2024年7月宣布“政府將投資1億英鎊建立五個量子研究中心”，詳細說明了這筆1億英鎊的投資將用於建立專門從事醫療感測和醫療保健的新中心。同樣，在2024年12月，惠康基金會（Wellcome Leap）的「量子生物」（Quantum for Bio）計畫也保持了強勁勢頭，為在人類健康領域展現量子優勢的計劃提供高達4000萬美元的研究經費。

市場挑戰

全球醫療保健量子運算市場的主要障礙在於硬體穩定性的技術成熟度不足，尤其是在應對高錯誤率和維持量子位元相干性方面面臨許多挑戰。在基因組學和製藥領域，分子模擬對於患者安全和藥物療效至關重要，需要絕對的精度，而目前「噪聲中等規模量子（NISQ）」處理器往往無法維持複雜計算所需的狀態保真度。這種不穩定性使得量子系統無法可靠地用於監管層級的數據處理，迫使生命科學公司只能將其應用限制在實驗性試驗計畫中，而無法將這項技術整合到關鍵的研發流程中。

雪上加霜的是，解決複雜物理問題和加速開發容錯硬體所需的熟練工程師嚴重短缺。根據量子經濟發展聯盟（QED-C）預測，到2025年，全球量子產業將面臨嚴重的人才短缺，屆時將有超過7,400個技術職缺。這種熟練人才的短缺將直接延緩降低錯誤率所需的技術突破，阻礙量子解決方案在醫療保健領域的商業性可行性，並抑制整體市場擴張。

市場趨勢

量子運算與人工智慧 (AI) 和機器學習的融合正在重塑市場格局，突破了傳統 AI 在分子模擬領域的運算極限。這一趨勢利用大規模定量模型和量子思維演算法產生精確的 AI 訓練數據，從而以前所未有的精度模擬複雜的生物系統。透過將基於物理的量子模擬與加速計算相結合，研究人員可以模擬以前無法建模的酶活性位點和催化劑。正如 2024 年 7 月的新聞稿《SandboxAQ 支持下一代 AI 驅動化學的實現》中所述，SandboxAQ 與 NVIDIA 的聯合研究已使量子化學計算速度比傳統的基於 CPU 的方法快 80 倍，顯著縮短了藥物發現過程。

此外，採用混合量子-經典運算架構正逐漸成為克服目前雜訊中等規模量子（NISQ）硬體限制的關鍵策略。在這種模式下，製藥公司利用量子處理器解決特定的運算密集型子問題，例如分子折疊，同時將剩餘的工作負載卸載到經典超級電腦。這種方法使企業能夠即時從量子系統開發中獲益，而無需等待完全容錯的機器。例如，在2024年6月發布的題為「Moderna和IBM展示用於mRNA二級結構預測的量子-經典方法」的公告中，IBM和Moderna展示了一種混合工作流程，該流程使用80個量子位元成功模擬了多達60個鹼基對的mRNA二級結構。這是一個創紀錄的規模，並展示了混合系統在複雜藥物設計中日益成長的效用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：醫療保健領域量子運算的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按組件（硬體、軟體、服務）
  • 透過技術（超導性位元、囚禁離子、量子退火等）
  • 按應用領域（藥物發現/開發、醫學診斷、基因組學/精準醫學、放射治療、風險分析等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美醫療保健領域量子運算市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲醫療保健領域量子運算市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區醫療保健領域量子運算市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲醫療保健領域量子運算市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲醫療保健領域量子運算市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球醫療保健量子運算市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• IBM Corporation
• Google LLC
• Microsoft Corporation
• Intel Corporation
• Honeywell International Inc.
• D-Wave Systems Inc.
• Amazon.com, Inc.
• IonQ, Inc.
• Rigetti Computing, Inc.
• Accenture plc

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Quantum Computing in Healthcare Market is projected to expand from USD 138.94 Billion in 2025 to USD 1173.69 Billion by 2031, achieving a CAGR of 42.71%. This field involves applying quantum mechanical principles, specifically entanglement and superposition, to process intricate biological and chemical data at speeds exponentially exceeding those of classical supercomputers. The market is primarily driven by the urgent need to expedite pharmaceutical drug discovery pipelines and the growing demand for high-precision genomic analysis to facilitate personalized medicine. These requirements necessitate advanced simulation capabilities capable of modeling molecular interactions with an accuracy that traditional computational methods cannot match, thereby significantly lowering research and development costs.

However, the market faces substantial obstacles regarding technical maturity, particularly the difficulty of maintaining qubit coherence and managing error rates within noisy environments. This hardware instability currently restricts the scalability of practical applications, necessitating a cautious integration strategy. The experimental nature of the technology is highlighted by the Pistoia Alliance, which reported that in 2025, approximately 18% of life sciences organizations anticipated utilizing quantum computing in their laboratories, a figure that underscores the engineering hurdles that persist despite the technology's transformative potential.

Market Driver

The most significant driver for the Global Quantum Computing in Healthcare Market is the ability to accelerate molecular simulation and drug discovery. Traditional computational methods frequently fail to model the complexity of molecular interactions with the necessary precision, creating bottlenecks in pharmaceutical R&D. Quantum algorithms overcome this by simulating chemical processes at the atomic level, significantly reducing both the time and capital required to identify viable drug candidates. This potential has prompted major industry players to allocate substantial resources; for instance, according to a May 2024 press release titled 'Novo Holdings Commits DKK 1.4 Billion to Quantum Technology Start-Up Ecosystem,' Novo Holdings allocated EUR 188 million specifically to advance quantum technologies with direct life sciences applications.

A second critical factor propelling market growth is the rise in public and private investments, which provide the essential infrastructure for these experimental technologies to mature. Governments and private entities are establishing dedicated hubs to address hardware instability and scale practical use cases in diagnostics and treatment. For example, the UK Government announcement 'Government invests £100m in five quantum research hubs' in July 2024 detailed a £100 million investment to establish new centers, including those focused on medical sensing and healthcare. Similarly, in December 2024, Wellcome Leap's Quantum for Bio program continued its momentum by advancing projects eligible for up to $40 million in research funding to demonstrate quantum advantage in human health.

Market Challenge

The primary impediment to the Global Quantum Computing in Healthcare Market is the lack of technical maturity concerning hardware stability, specifically the challenge of managing high error rates and maintaining qubit coherence. In the genomic and pharmaceutical sectors, where molecular simulations demand absolute precision for patient safety and drug efficacy, current "Noisy Intermediate-Scale Quantum" (NISQ) processors often fail to maintain the state fidelity required for complex calculations. This instability makes quantum systems unreliable for regulatory-grade data processing, forcing life sciences organizations to restrict their engagement to experimental pilot programs rather than integrating the technology into critical R&D workflows.

Compounding this challenge is a severe shortage of the specialized engineering talent needed to solve these intricate physics problems and accelerate the development of fault-tolerant hardware. According to the Quantum Economic Development Consortium (QED-C), the global quantum industry faced a critical workforce gap in 2025, with more than 7,400 unfilled technical job openings. This scarcity of skilled human capital directly slows the engineering breakthroughs required to reduce error rates, thereby delaying the commercial viability of quantum solutions for healthcare applications and stifling overall market expansion.

Market Trends

The integration of Quantum Computing with Artificial Intelligence and Machine Learning is reshaping the market by transcending the computational limits of classical AI in molecular simulation. This trend involves using large quantitative models and quantum-inspired algorithms to generate precise training data for AI, enabling the modeling of complex biological systems with unprecedented accuracy. By combining physics-based quantum simulations with accelerated computing, researchers can simulate enzyme active sites and catalysts that were previously impossible to model. As noted in the 'SandboxAQ Helps Unlock the Next Generation of AI-Driven Chemistry' press release from July 2024, SandboxAQ's collaboration with NVIDIA achieved an 80x speedup in quantum chemistry calculations compared to traditional CPU-based methods, significantly shortening drug discovery timelines.

Additionally, the adoption of Hybrid Quantum-Classical Computing Architectures is emerging as a critical strategy to bypass the limitations of current noisy intermediate-scale quantum (NISQ) hardware. In this model, pharmaceutical companies utilize quantum processors to solve specific, computationally intensive sub-problems-such as molecular folding-while offloading remaining workloads to classical supercomputers. This approach allows organizations to derive immediate value from developing quantum systems without waiting for fully fault-tolerant machines. For instance, in the June 2024 announcement 'Moderna and IBM Demonstrate Quantum-Classical Approach for mRNA Secondary Structure Prediction,' IBM and Moderna revealed that their hybrid workflow successfully simulated mRNA secondary structures of up to 60 nucleotides using 80 qubits, a record-setting scale that demonstrates the growing utility of hybrid systems for complex therapeutic design.

Key Market Players

• IBM Corporation
• Google LLC
• Microsoft Corporation
• Intel Corporation
• Honeywell International Inc.
• D-Wave Systems Inc.
• Amazon.com, Inc.
• IonQ, Inc.
• Rigetti Computing, Inc.
• Accenture plc

Report Scope

In this report, the Global Quantum Computing in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Quantum Computing in Healthcare Market, By Component

• Hardware
• Software
• Services

Quantum Computing in Healthcare Market, By Technology

• Superconducting Qubits
• Trapped Ions
• Quantum Annealing
• Others

Quantum Computing in Healthcare Market, By Application

• Drug Discovery & Development
• Medical Diagnostics
• Genomics & Precision Medicine
• Radiotherapy
• Risk Analysis
• Others

Quantum Computing in Healthcare Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Quantum Computing in Healthcare Market.

Available Customizations:

Global Quantum Computing in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Quantum Computing in Healthcare Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Hardware, Software, Services)
  • 5.2.2. By Technology (Superconducting Qubits, Trapped Ions, Quantum Annealing, Others)
  • 5.2.3. By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Quantum Computing in Healthcare Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Quantum Computing in Healthcare Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Quantum Computing in Healthcare Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Quantum Computing in Healthcare Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application

7. Europe Quantum Computing in Healthcare Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Quantum Computing in Healthcare Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
  • 7.3.2. France Quantum Computing in Healthcare Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Quantum Computing in Healthcare Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Quantum Computing in Healthcare Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Quantum Computing in Healthcare Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application

8. Asia Pacific Quantum Computing in Healthcare Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Quantum Computing in Healthcare Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
  • 8.3.2. India Quantum Computing in Healthcare Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Quantum Computing in Healthcare Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Quantum Computing in Healthcare Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Quantum Computing in Healthcare Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application

9. Middle East & Africa Quantum Computing in Healthcare Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Quantum Computing in Healthcare Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Quantum Computing in Healthcare Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Quantum Computing in Healthcare Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application

10. South America Quantum Computing in Healthcare Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Quantum Computing in Healthcare Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Quantum Computing in Healthcare Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Quantum Computing in Healthcare Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Quantum Computing in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. IBM Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Google LLC
• 15.3. Microsoft Corporation
• 15.4. Intel Corporation
• 15.5. Honeywell International Inc.
• 15.6. D-Wave Systems Inc.
• 15.7. Amazon.com, Inc.
• 15.8. IonQ, Inc.
• 15.9. Rigetti Computing, Inc.
• 15.10. Accenture plc

16. Strategic Recommendations

17. About Us & Disclaimer